Patients with MS should be provided palliative care, which could help them manage symptoms more efficiently and could solve some psychosocial problems. Evaluating the satisfaction with provided care may be one of the factors of the quality of care evaluation.
Aim:
The aim of this controlled intervention study was to determine the factors affecting one’s satisfaction with care in patients in advanced stages of MS and their caregivers. Furthermore, the aim was to study the difference in the satisfaction of patients and family members with the provided specialized palliative care, as opposed to the standard care.
Methods:
The sample consisted of 103 patients with MS who were randomized to either a palliative care intervention or the control group. Family members of each patient were invited in the study, and 97 caregivers agreed to participe. The patients in the intervention group were provided with neuropalliative care in the form of consultations with a multidisciplinary palliative team. A modified questionnaire, CANHELP Lite, was used to collect data. Patients and family members completed the questionnaire 3 months after the intervention.
Results:
The patients and caregivers in the intervention group expressed significantly greater satisfaction in all analyzed areas (p = 0.000-0.002). The provided intervention predicted the satisfaction in the domains of a relationship with the doctor, disease management, and decision-making/communication. Another important predictor of the satisfaction in all domains was the functional state of the patient.
Conclusion:
Targeted consultations resulted in the greater satisfaction of patients with MS and their caregivers with the provided care.
EdmondsPHartSGaoW, et al.Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Mult Scler. 2010;16(5):627–636.
2.
GollaHGalushkoMPfaffH, et al.Multiple sclerosis and palliative care—perception of severely affected multiple sclerosis patients and their professionals: a qualitative study. BMC Palliat Care. 2014;13(1):11.
3.
ScalfariAKnappertzVCutterG, et al.Mortality in patients with multiple sclerosis. Neurol. 2013;81(2):184–192.
4.
LatorracaCOCMartimbiancoALCPachitDV, et al.Palliative care interventions for people with multiple sclerosis (Protocol). Cochrane Database Systc Rev. 2018;1(CD012936).
5.
HepgulNGaoWEvansCJ, et al.Integrating palliative care into neurology services: what do the professionals say?BMJ Support Palliat Care. 2018;8(1):41–44.
6.
VanopdenboschLJCambronM. There is an urgent need for palliative care specialists in MS. Mult Scler J. 2019;25(13):1712–1713.
7.
SolariAGiordanoASastre-GarrigaJ, et al.EAN guideline on palliative care of people with severe, progressive multiple sclerosis. J Palliat Med. 2020;27(8):1510–1529. doi:10.1089/jpm.2020.0220
8.
HigginsonIJHartSSilberE, et al.Symptom prevalence and severity amongst people severely affected by multiple sclerosis (MS). J Palliat Care. 2006;22(3):158–165.
9.
O’BrienT. Neurodegenerative disease. In: AddingtonHallJMHigginsonIJ, eds. Palliative Care for Non-Cancer Patients. Oxford University Press; 2001:44–55.
10.
KümpfelTHoffmannLAPöllmannW, et al.Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists. Palliat Med. 2007;21(2):109–114.
11.
StruppJVoltzRGollaH.Opening locked doors: integrating a palliative care approach into the management of patients with severe multiple sclerosis. Mult Scler J. 2016;22(1):13–18.
12.
Leclerc-LoiselleJLegaultA. Introduction of a palliative approach in the care trajectory among people living with advanced MS: perceptions of home-based health professionals. Int J Palliat Nurs. 2018;24(6):264–270.
13.
CheongWOMohanDWarrenN, et al.Accessing palliative care for multiple sclerosis: a qualitative study of a neglected neurological disease. Mult Scler Relat Dis. 2019;35:1–6.
14.
VališMPavelekZ. Pacient s roztroušenou sklerózou v současném systému. Med praxis. 2017;14(5):253–257.
15.
BeckerVHeeschenVSchuhK, et al.Patient satisfaction and healthcare services in Germany. Ther Adv Neurol. Dis2018;11(1):1–2.
16.
AspinalFAddington-HallJHughesR, et al.Using satisfaction to measure the quality of palliative care: a review of the literature. J Adv Nurs. 2003;42(4):324–339.
17.
KavalieratosDCorbelliJZhangBS, et al.Association between palliative care and patient and caregiver outcomes. JAMA. 2016;316(20):2104–2114.
18.
BužgováRKozákováRBarM, et al.Pain, physical symptoms and functional assessment in progressive neurological disease in palliative care. BMJ Support Palliat Care. 2020. Epub ahead of print 13 August 2020. doi:10.1136/bmjspcare-2020-002416
19.
BužgováRKozákováRBarM, et al.The effect of neuropalliative care on quality of life and satisfaction with quality of care in patients with progressive neurological disease and their family caregivers: an interventional control study. BMC Palliat Care. 2020;19(1):143.
20.
RingdalGIJodhoyMSKaasaS. Measuring quality of palliative care: psychometric properties of the FAMCARE scale. Qual Life Res. 2003;12(2):167–176.
21.
YamagishiAMoritaTMiyashitaM, et al.Pain intensity, quality of life, quality of palliative care, and satisfaction in outpatients with metastatic or recurrent cancer: a Japanese, nationwide, region-based, multicenter survey. J Pain Symptom Manag. 2012;43(3):503–514.
22.
WentlandtKSeccarecciaDKevorkM, et al.Quality of care and satisfaction with care on palliative care units. J Pain Symptom Manag. 2016;51(2):184–192.
23.
AboshaiqahASaediTSBAbu-Al-RuyhaylahM, et al.Quality of life and satisfaction with care among palliative cancer patients in Saudi Arabia. Palliat Support Care. 2016;14(6):621–627.
24.
UllrichAAscherfeldLMarxG, et al.Quality of life, psychological burden, needs, and satisfaction during specialized inpatient palliative care in family caregivers of advanced cancer patient. BMC Palliat Care. 2017;16(1):1–10.
25.
KurtzkeJF.Rating neurologic impairment in multiple sclerosis. An Expanded Disability Status Scale (EDSS). Neurol. 1983;33(11):1444–1452.
26.
AndersonF.DowningGMHillJ, et al.Palliative Performance Scale (PPS): a new tool. J Palliat Care. 1996;12(1):5–11.
27.
HeylandDKJiangXDayAG, et al.The development and validation of shorter version of the Canadian health care evaluation project questionnaire (CANHELP Lite): a novel tool to measure patient and family satisfaction with end-of-life care. J Pain Symptom Manag. 2013;46(2):289–297.
28.
Meyer-MoockSFengYMaeurerM, et al.Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 2014;14(1):58.
29.
HoFLauFDowningMG, et al.A reliability and validity study of the Palliative Performance Scale. BMC Palliat Care. 2008;7(1):10.
30.
YohannesAMDoddMMorrisJ, et al.Reliability and validity of a single item measure of quality of life scale for adult patients with cystic fibrosis. Health Qual Life Outcomes. 2011;9(1):105.
31.
SolariAGiordanoAPattiF, et al.Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis. Mult Scler J. 2018;24(5):663–674.
32.
HigginsonIJMcCronePHonsBS, et al.Is short-term palliative care cost effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage. 2009;38(6):816–826.
33.
LeeYYooJWHuaL. Ten-year trends of palliative care utilization associated with multiple sclerosis patients in the United Stated from 2005 to 2014. J Clin Neurosci2018;58:13–19.
34.
WollinJAYatesPMKristjansonLJ. Supportive and palliative care needs identified by multiple sclerosis patients and their families. Int J Palliat Nurs. 2013;12(1):20–26.
35.
StruppJGroebeBKniesA, et al.Evaluation of a palliative and hospice care telephone hotline for patients severely affected by multiple sclerosis and their caregivers. Eur J Neurol. 2017;24(12):1518–1524.
36.
TintoréMAlexanderMCostelloK, et al.The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Prefer Adherence. 2017;11:33–45.
37.
MattarozziKBaldinEZenesiniC, et al.Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centers. Eur J Neurol. 2017;24(4):631–637.
38.
ThachABrownCMHerreraV, et al.Associations between treatment satisfaction, medication beliefs, and adherence to disease-modifying therapies in patients with multiple sclerosis. Int J MS Care. 2018;20(6):251–259.
